COSTEM 2019 | Preventing relapse post-transplant in AML and MDS?

Marcos de Lima

Marcos de Lima, MD, University Hospitals Cleveland Medical Center, Cleveland, OH, outlines the current guidelines in preventing relapse in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video